International consensus report on the investigation and management of primary immune thrombocytopenia
Drew Provan, Roberto Stasi(National Health Service), Adrian C. Newland, Victor S. Blanchette(University of Toronto), Paula Bolton‐Maggs(Manchester Royal Infirmary), James B. Bussel, Beng H. Chong(UNSW Sydney), Douglas B. Cines(Hospital of the University of Pennsylvania), Terry Gernsheimer(University of Washington), Bertrand Godeau(Assistance Publique – Hôpitaux de Paris), John D. Grainger(Royal Manchester Children's Hospital), Ian Greer(University of York), Beverley J. Hunt(National Health Service), Paul Imbach(University Children’s Hospital Basel), G. Lyons(St James's University Hospital), Robert McMillan(Scripps Research Institute), Francesco Rodeghiero(Ospedale San Bortolo), Miguel Á. Sanz(Hospital Universitari i Politècnic La Fe), Michael D. Tarantino(Bleeding & Clotting Disorders Institute), Shirley Watson, Joan Young, David J. Kuter(Harvard University)
Cited by 2,261Open Access
Abstract
Over the last decade, there have been numerous developments and changes in treatment practices for the management of patients with immune thrombocytopenia (ITP). This article is an update of the International Consensus Report published in 2010. A critical review was performed to identify all relevant articles published between 2009 and 2018. An expert panel screened, reviewed, and graded the studies and formulated the updated consensus recommendations based on the new data. The final document provides consensus recommendations on the diagnosis and management of ITP in adults, during pregnancy, and in children, as well as quality-of-life considerations.
Related Papers
No related papers found
Powered by citation graph analysis